Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
3.530
+0.190 (5.69%)
Jan 21, 2025, 4:00 PM EST - Market closed
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $443.81 million as of January 22, 2025. Its market cap has decreased by -9.89% in one year.
Market Cap
443.81M
Enterprise Value
457.14M
1-Year Change
-9.89%
Ranking
Category
Stock Price
$3.53
Market Cap Chart
Since January 5, 2017, Organogenesis Holdings's market cap has increased from $376.60M to $443.81M, an increase of 17.85%. That is a compound annual growth rate of 2.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 468.00M | 10.33% |
| Dec 31, 2024 | 424.20M | -21.44% |
| Dec 29, 2023 | 540.00M | 53.32% |
| Dec 30, 2022 | 352.20M | -70.37% |
| Dec 31, 2021 | 1.19B | 46.45% |
| Dec 31, 2020 | 811.60M | 78.10% |
| Dec 31, 2019 | 455.70M | 30.13% |
| Dec 31, 2018 | 350.20M | -8.90% |
| Dec 29, 2017 | 384.40M | 2.07% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 341.33B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |